Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Organisation › Details

SR One Ltd.

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested in more than 135 companies. *


Period Start 1985-01-01 established
  Group GlaxoSmithKline (GSK) (Group)
Products Industry venture capital
  Industry 2 pharmaceutical
  Street 161 Washington Street
  City 19428-2077 Conshohocken, PA
  Tel +1-610-567-1000
    Address record changed: 2018-07-24
Basic data Employees n. a.
    * Document for �About Section�: F-Star Biotechnologische Forschungs- und Entwicklungsges. m.b.H.. (4/13/11). "Press Release: F-Star Raises €15M in a New Financing Led by SR One. To Progress Product Candidates into Development and Maximise Potential of the Molecular Antibody Technology
Record changed: 2018-10-31


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for GlaxoSmithKline (GSK) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top